Figure 3a shows representative western blots of the UPR protein ATF4 for the CML cell lines K562, BV173, and KU812, and the BCR::ABL1-negative cell line HL60, treated with/without imatinib and oligomycin. Here, ATF4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.